These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 24899477

  • 1. Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW).
    Kızılırmak P, Ar I, Ilerigelen B.
    Turk Kardiyol Dern Ars; 2014 Jun; 42(4):339-48. PubMed ID: 24899477
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of valsartan and amlodipine single-pill combination in hypertensive patients (PEAK study).
    Kızılırmak P, Berktaş M, Yalçın MR, Boyacı B.
    Turk Kardiyol Dern Ars; 2013 Jul; 41(5):406-17. PubMed ID: 23917006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W, Moin N, Iktidar S, Sakrani J, Abid R, Afzal J, Maheshwary N, Kumar K, Siddiqi A, Qadir M.
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
    Schunkert H, Glazer RD, Wernsing M, Yen J, Macarie CE, Vintila MM, Romanova J.
    Curr Med Res Opin; 2009 Nov; 25(11):2655-62. PubMed ID: 19751115
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Braun N, Ulmer HJ, Ansari A, Handrock R, Klebs S.
    Curr Med Res Opin; 2009 Feb; 25(2):421-30. PubMed ID: 19192987
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.
    Sinkiewicz W, Glazer RD, Kavoliuniene A, Miglinas M, Prak H, Wernsing M, Yen J.
    Curr Med Res Opin; 2009 Feb; 25(2):315-24. PubMed ID: 19192976
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ, Goldflus S, McQuitty M, Oigman W, Valsartan/HCTZ Combination Therapy in Brazil Study Group.
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [Abstract] [Full Text] [Related]

  • 11. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 12. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S.
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [Abstract] [Full Text] [Related]

  • 13. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study.
    Smith TR, Glazer RD, Koren MJ, Wernsing M, Zhang Y.
    Int J Clin Pract; 2010 Sep; 64(10):1367-74. PubMed ID: 20716145
    [Abstract] [Full Text] [Related]

  • 17. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 18. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S, Edwards C, Jones R, TEAMSTA-10 Investigators.
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
    Ke YN, Huang J, Zhu JR, Valsartan/Amlodipine Single Pill Combination Study Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
    [Abstract] [Full Text] [Related]

  • 20. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA, Crikelair NA, Yen J, Glazer RD.
    Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.